申请人:GIVAUDAN SA
公开号:WO2010037244A2
公开(公告)日:2010-04-08
Disclosed are compounds having the ability to modulate, namely to improve, enhance and/or modify fragrance compositions due to their ability to inhibit cytochrome P450 enzymes, e.g. CYP2A, e.g. 2A13 and 2A6, and CYP2B6.